Protection from cancer in kidney transplant patients by γδ T cells: Role of CMV Infection?

Journal of the American Society of Nephrology

Volumn 21, Issue 1, 2010, Pages 11-13

  Söderberg Nauclér, Cecilia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; CYTOMEGALOVIRUS INFECTION; EDITORIAL; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOTHERAPY; KIDNEY CANCER; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; T LYMPHOCYTE; TUMOR GROWTH; VIRUS REPLICATION;

EID: 75149152421     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111166     Document Type: Editorial

References (15)

1. Couzi L, Levaillant Y, Jamai A, Pitard V, Lassalle R, Martin K, Garrigue I, Hawchar O, Siberchicot F, Moore N, Moreau JF, Dechanet-Merville J, Merville P: Cytomegalovirus-induced γδ T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 21: 181-188, 2010
2. Deknuydt F, Scotet E, Bonneville M: Modulation of inflammation through IL-17 production by gammadelta T cells: Mandatory in the mouse, dispensable in humans? Immunol Lett 127: 8-12, 2009
3. Hayday AC: Gamma delta cells: A right time and a right place for a conserved third way of protection. Annu Rev Immunol 18: 975-1026, 2000
4. Groh V, Steinle A, Bauer S, Spies T: Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279: 1737-1740, 1998
5. Dechanet J, Merville P, Berge F, Bone-Mane G, Taupin JL, Michel P, Joly P, Bonneville M, Potaux L, Moreau JF: Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis 179: 1-8, 1999
6. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF: Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 103: 1437-1449, 1999
7. Lafarge X, Merville P, Cazin MC, Berge F, Potaux L, Moreau JF, Dechanet-Merville J: Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 184: 533-541, 2001
8. Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Dechanet-Merville J: Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 112: 1317-1324, 2008
9. Soderberg-Naucler C: Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259: 219-246, 2006
10. Michaelis M, Doerr HW, Cinatl J: The story of human cytomegalovirus and cancer: Increasing evidence and open questions. Neoplasia 11: 1-9, 2009
11. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ: Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62: 3347-3350, 2002
12. Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK, Slinger E, Schreiber A, Michel D, Tensen CP, van Dongen GA, Leurs R, Smit MJ: The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 69: 2861-2869, 2009
13. Prins RM, Cloughesy TF, Liau LM: Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359: 539-541, 2008
14. Lamb LS Jr: Gammadelta T cells as immune effectors against high-grade gliomas. Immunol Res 45: 85-95, 2009
15. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC: Regulation of cutaneous malignancy by gammadelta T cells. Science 294: 605-609, 2001